secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001628908-22-000138
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health Q3 2022 revenue up 58.5% to $352.6M; net income $2.1M
--------------------------------------------------------------------

- Revenue of $352.6M, +58.5% YoY; net income $2.1M (0.6% margin).
- Adjusted EBITDA of $28.1M (8.0% margin), vs prior-year loss.
- Total lives on platform 19.5M; EHS 2.1M, Clinical Solutions 17.4M.
- Signed 3 new operating partnerships, including Molina Healthcare expansion and WA ACO for 2023 MSSP.
- Dan McCarthy promoted to President; Kali Beyah appointed Chief People and Brand Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890822000138/0001628908-22-000138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890822000138/evh-20221102.htm
  HTML page:      https://secwatch.observer/filing/0001628908-22-000138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer